YKL-40 as a new promising prognostic marker of severity in COVID infection
Open Access
- 16 February 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 25 (1), 1-4
- https://doi.org/10.1186/s13054-020-03383-7
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive PhenotypeSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2020
- Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literatureRheumatology, 2019
- Blood Biomarkers in Idiopathic Pulmonary FibrosisLung, 2017
- Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosisRespiratory Medicine, 2011
- YKL-40 Is Elevated in Patients with Chronic Obstructive Pulmonary Disease and Activates Alveolar MacrophagesThe Journal of Immunology, 2008
- High serum levels of YKL‐40 in patients with systemic sclerosis are associated with pulmonary involvementScandinavian Journal of Rheumatology, 2005